In this interview, Yehuda Handelsman, MD, highlights key updates to the Diabetes, Cardiorenal, and Metabolic (DCRM) guidelines in DCRM 2.0, shaped by global collaboration and recent clinical insights.

On December 5, 2024, the U.S. Food and Drug Administration (“FDA”) issued a much anticipated draft guidance for industry on accelerated approval ...

The challenges and innovative solutions to spreading evidence-based medical research across China in order to improve the ...

USA: The World Health Organization (WHO) has issued updated guidelines on the administration of oxytocin for the prevention ...

A recently published, comprehensive systematic review and meta-analysis has added to the growing body of evidence showing ...

The Institute for Clinical and Economic Review assessed the formularies of 11 payers, covering 57 million people, to ...

Cystic fibrosis, a genetic disease that attacks the lungs, affects roughly 1 in 3,000 people, and cystic fibrosis-related ...

Sun, Y. , Cheng, X. and Pen, K. (2024) Clinical Value of Platelet-Related Parameters and Monocyte Counts in Patients with ...

Myriad Genetics, Inc. MYGN is driving innovation across Oncology, Women's Health and Pharmacogenomics, and heavily invests in labs and digital capabilities. Thecompany’s Oncology growth strategy ...

The devastating news of a cancer diagnosis understandably makes doctors and patients focus on the cancer itself.

Advisers on the national dietary guidelines issue a report, minus ultra-processed foods, promoting a new motto: "Eat Healthy ...

This homepage example combines setting the perfect tone through distilled messaging, imagery, and color scheme. Everything is simplified so the user can relax, discover, and enjoy the website.